DOCSLIB.ORG

Curriculum Vitae for Prof Søren M

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae for Prof Søren M CURRICULUM VITÆ FOR PROFESSOR SØREN M. BENTZEN Full Name: Søren Møller Bentzen Title: Professor, Director of the Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, Director of the University of Maryland Greenebaum Comprehensive Cancer Center Biostatistics Shared Service, Director of the Biostatistics Core of the Institute of Clinical and Translational Research, and Director of Translational Research, Maryland Proton Therapy Alliance, University of Maryland School of Medicine Academic Credentials : M.Sc., Ph.D., D.M.Sc., F.A.S.T.R.O. Affiliations: Professor, tenured, Department of Epidemiology and Public Health, primary faculty appointment, University of Maryland School of Medicine, Baltimore, MD, USA Professor of Radiation Oncology, secondary faculty appointment, University of Maryland School of Medicine, Baltimore, MD, USA Director, Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA Director, University of Maryland Greenebaum Comprehensive Cancer Center Biostatistics Shared Service, University of Baltimore School of Medicine, Baltimore, MD, USA Director, Biostatistics Core, Institute for Clinical and Translational Research, University of Maryland Baltimore, Baltimore, MD, USA Director of Translational Research, Maryland Proton Alliance, University of Baltimore School of Medicine, Baltimore, MD, USA Member, University of Maryland Greenebaum Comprehensive Cancer Center, Experimental Therapeutics Program, University of Baltimore School of Medicine, Baltimore, MD, USA Member, Graduate Faculty of the University of Maryland Graduate School, Baltimore; Affiliated with the Epidemiology and Human Genetics Program and the Molecular Medicine Program Affiliate Member, Institute for Global Health (IGH), University of Baltimore School of Medicine, Baltimore, MD, USA Research Associate without Compensation, Department of Veterans Affairs Medical Center, Maryland Health Care System, Baltimore, MD, USA Adjunct Professor, Department of Oncology, University of Copenhagen, Denmark Visiting Professor, Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Birth Date and Place: March 13, 1956 in Aarhus, Denmark Citizenship: U.S. citizen Home Address: Baltimore, Maryland, U.S.A. Office Address: 600 W. Redwood Street, Howard Hall 109D, Baltimore, MD 21201, U.S.A. Phone: +1 410-706-8505 Fax: +1 410-706-8548 Email: [email protected] Academic degrees: D.M.Sc. (Doctor of Medical Science), Medicine/Clinical Radiobiology, U of Aarhus, Denmark, 1994. Prof. Søren M. Bentzen, PhD, DMSc Page 1 of 70 August 20, 2021 Ph.D. in Medicine/Medical Physics, University of Aarhus, Denmark, 1986. M.Sc. in Physics, University of Aarhus, Denmark, 1981. B.Sc. in Physics & Mathematics, University of Aarhus, Denmark, 1978. Academic and Professional Appointments: 11/13 – Professor, tenured, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA 02/14 – Professor, Department of Radiation Oncology, secondary faculty appointment, University of Maryland School of Medicine, Baltimore, MD, USA 01/18 – Director of the Biostatistics Core of the Institute of Clinical and Translational Research, University of Maryland Baltimore, Baltimore, MD, USA 11/13 – Director of the Division of Biostatistics and Bioinformatics; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA 11/13 – Director of the University of Maryland Greenebaum Comprehensive Cancer Center Biostatistics Shared Service, Baltimore, MD, USA 7/16 – Director of Translational Proton Therapy Research, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA 05/14 – Member, Experimental Therapeutics Program, University of Maryland Greenebaum Comprehensive Cancer Center, University of Baltimore School of Medicine, Baltimore, MD, USA 05/14 – Regular Member of the Graduate Faculty of the University of Maryland Graduate School, Baltimore; Affiliated with the Epidemiology and Human Genetics Program and the Molecular Medicine Program 10/16 – Affiliate Member, Institute for Global Health (IGH), University of Baltimore School of Medicine, Baltimore, MD, USA 09/16 – Research Associate without Compensation, Department of Veterans Affairs Medical Center, Maryland Health Care System, Baltimore, MD, USA 09/07 – Adjunct Professor of Radiation Biology and Medical Physics, University of Copenhagen, Denmark 10/15 – Visiting Professor, Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA 03/08 – 10/13 Varian Visiting Professor to the Radiation Therapy Oncology Group, RTOG, Philadelphia, PA, USA. 12/05 – 10/13 Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA 12/05 – 10/13 Professor of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA 12/07 – 10/13 Professor of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA 02/06 - 10/13 Member of the Imaging and Radiation Sciences Program, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA 12/04 – 3/11 Director of Research and Education of Human Oncology, Vice Chair for Research, Department of Human Oncology, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA 06/10 – 11/11 Program Leader, Imaging and Radiation Sciences Program, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA 02/06 – 06/10 Co-Lead of the Imaging and Radiation Sciences Program, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA 02/05 – 12/05 Visiting Professor of Medical Physics, University of Wisconsin Medical School, Madison, WI, USA 12/04 – 12/05 Visiting Professor of Human Oncology, University of Wisconsin Medical School, Madison, WI, USA 01/98 – 12/04 Group Head, Group for Human Cancer Biology & Informatics, Gray Cancer Institute, Mount Vernon Hospital, Northwood, UK 02/98 – 06/02 Head of Information Technology, Gray Cancer Institute, Northwood UK. 01/97 - 12/97 Associate Professor, Institute of Clinical Science, University of Aarhus, Aarhus, Denmark 09/92 - 12/97 Clinical Lecturer in Oncology (Basic and clinical radiobiology), University of Aarhus, Denmark. 01/90 - 12/96 Senior Scientist, Danish Cancer Society, Dept. of Experimental Clinical Oncology in Aarhus, Denmark. Prof. Søren M. Bentzen, PhD, DMSc Page 2 of 70 August 20, 2021 08/88 - 12/89 Hospital Physicist, Dept. of Medical Physics, Radiumstationen, Aarhus University Hospital, Denmark. 08/87 - 07/88 Visiting Scientist, Dept. of Biomathematics, U of Texas, M.D. Anderson Cancer Center, Houston, U.S.A. 06/83 - 07/87 Hospital Physicist, Radiophysics Laboratory, Radiumstationen, Aarhus University Hospital, Denmark. 01/82 - 05/83 Postgraduate research Fellow, Danish Cancer Society, Denmark. 09/81 - 12/81 Assistant Professor, Institute of Physics, University of Aarhus, Denmark. 06/81 - 08/81 Hospital Physicist, Radiophysics Laboratory, Radiumstationen, Aarhus University Hospital, Denmark. 08/80 - 06/81 Research scholarship in atomic physics from the University of Aarhus, Denmark. Honorary and Visiting appointments: 12/00 – 11/05 Honorary Professor, Department of Oncology, University College London, UK 04/98 – 12/04 Visiting Statistician, Medical Research Council, Clinical Trials Office, London, UK 11/99 – 12/05 External Examiner, Therapeutic Radiography (Senior Examiner & Chair of Examination Committee, 2002–2005), University of Dublin, Faculty of Health Sciences, Trinity College, Dublin, Ireland 01/98 – 12/04 Honorary Research Consultant, West Hertfordshire NHS Trust, UK 06/00 – 09/04 Member of the Examining Board for the First Examination for the Fellowship in Clinical Oncology, Royal College of Radiologists, London, UK 08/00 Visiting Professor, Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 12/98 - 12/00 Visiting Professor, Department of Oncology, University College London, UK 02/98 - 11/98 Honorary Senior Lecturer, Department of Oncology, University College London, London UK 01/97 – 04/06 Visiting Professor (about 1-2 visits of 3 days’ duration per year) in the Department of Radiation Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland 06/95 - 08/95 Visiting Professor, Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston, Texas Consultantships: 11/02 Research Consultant, Dept. of Radiation Therapy, University Hospital of Copenhagen, Denmark 10/93 - 12/97 Research Consultant, Danish Physiotherapy Research Foundation, Denmark 9/86 - 12/97 Statistical Consultant, Danish Medical Research Council, Denmark 12/85 - 1/91 Senior Consultant in Clinical Radiation Physics, Dept. of Oncology, Vejle, Denmark 12/86 Consulting Biostatistician with the Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus, Denmark Honors & Awards (31): 2020 Honorary Life Member, German Society of Radio-oncology (DEGRO) 2018 Fellow of the American Society for Radiation Oncology (FASTRO) 2017 Seoul National University Hospital Distinguished Lecturer, Seoul, Republic of Korea 2017 Gold Medal, American Society for Radiation Oncology (ASTRO) 2016 Gilbert H. Fletcher Distinguished Lecturer, International Conference
Load more

Recommended publications
  • Bibliography of Education, 1911-11
    I UNITEDSTATESBUREAU ,OFEDUCATION 657 BULLETIN, 1915, NO. 30 - - - WHOLE NUMBER BIBLIOGRAPHYOFEDUCATION FOR 19,1 1-1 2 a at, Ab. WASHINGTON GOVERNMENT PRINTINGOFFICE 1915 ADDITIONAL COPIES PIMLICATION MAT DR PROCUREDFROM THE '1:PERIN-TENDERT OrDOCUMENTS GOVERNMENT PRINTING OPTICS WASHINGTON, D. C. AT 2O CENTS PER COPY 205570 .A AUG 28 1918 athl 3 a -3g CONTENTS. i9IS 30 -3 8 Generalities: Bibliography Page. New periodicals 7 9 Pulaications of associations, sociefies, conferences,etc. National State and local 9 14(i' Foreign 23 International Documents 23 Encyclopedias 23 24 History and description: General Ancient 24 25 Medieval 25 odena 25 United States . Ge.neral 25 Public-school system 28 Secondary education 28 Higher or university education 29 National education association 30 Canada s 30 South AmericaWest Indies 31 Great Britain 31 Secondary education 32 Higher or university education 32 Austria 32 France 33 Germany 33 Higher or university education 34 Italy Belgium 35 Denmark 35 Sweden 35 Iceland 35 Switzerland 35 Asia 35 .China 35 India Japan 38 Now Zealand 38 Philippine Islands 38' Biography 37 Theory of education 38 Principles and practice of teaching: General 42 Special methods of instruction 44 Moving pictures, phonographs, etc 44 Methods of study.. 45 Educational psychology 45 Child study 48 Child psychology 49 Plays, games, etc 49 4 CONTENTS. Principles and practice of teachingContinued. Pais. Kindergarten and primary education 50 Montessori method 52 Elementary or common-school education 54 Rural schools. 54 Curriculum. 57 Reading . 58 Penmanship 58 . Spelling 58 Composition and language study 59 Languages 59 History 59 Geography 59 Nature study and science 60 Arithmetic .
    [Show full text]
  • (TPZ) Prodrugs for the Management of Hypoxic Solid Tumors by Sindhuja
    Evaluation of bioreductively-activated Tirapazamine (TPZ) prodrugs for the management of hypoxic solid tumors by Sindhuja Pattabhi Raman A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Cancer Sciences Department of Oncology University of Alberta © Sindhuja Pattabhi Raman, 2019 Abstract Solid tumors often have large areas with low levels of oxygen (termed hypoxic regions), which are associated with poor prognosis and treatment response. Tirapazamine (TPZ), a hypoxia targeting anticancer drug, started as a promising candidate to deal with this issue. However, it was withdrawn from the clinic due to severe neurotoxic side effects and poor target delivery. Hypoxic cells overexpress glucose transporters (GLUT) - a key feature during hypoxic tumor progression. Our project aims at conjugating TPZ with glucose to exploit the upregulated GLUTs for its delivery, and thereby facilitate the therapeutic management of hypoxic tumors. We hypothesized that glucose-conjugated TPZ (G6-TPZ) would be selectively recruited to these receptors, facilitating its entrapment in poorly oxygenated cells only, with minimal damage to their oxygenated counterparts. However, our results reveal that the addition of the glucose moiety to TPZ was counterproductive since G6-TPZ displayed selective hypoxic cytotoxicity only at very high concentrations of the compound. We speculate that the reduced cytotoxicity of G6-TPZ might be due to the fact that the compound was not taken up by the cells. In order to monitor the cellular uptake of TPZ, we developed a click chemistry-based approach by incorporating an azido (N3) group to our parent compound (N3-TPZ). We observed that the azido-conjugated TPZ was highly hypoxia selective and the compound successfully tracks cellular hypoxia.
    [Show full text]
  • The Dark Unknown History
    Ds 2014:8 The Dark Unknown History White Paper on Abuses and Rights Violations Against Roma in the 20th Century Ds 2014:8 The Dark Unknown History White Paper on Abuses and Rights Violations Against Roma in the 20th Century 2 Swedish Government Official Reports (SOU) and Ministry Publications Series (Ds) can be purchased from Fritzes' customer service. Fritzes Offentliga Publikationer are responsible for distributing copies of Swedish Government Official Reports (SOU) and Ministry publications series (Ds) for referral purposes when commissioned to do so by the Government Offices' Office for Administrative Affairs. Address for orders: Fritzes customer service 106 47 Stockholm Fax orders to: +46 (0)8-598 191 91 Order by phone: +46 (0)8-598 191 90 Email: [email protected] Internet: www.fritzes.se Svara på remiss – hur och varför. [Respond to a proposal referred for consideration – how and why.] Prime Minister's Office (SB PM 2003:2, revised 02/05/2009) – A small booklet that makes it easier for those who have to respond to a proposal referred for consideration. The booklet is free and can be downloaded or ordered from http://www.regeringen.se/ (only available in Swedish) Cover: Blomquist Annonsbyrå AB. Printed by Elanders Sverige AB Stockholm 2015 ISBN 978-91-38-24266-7 ISSN 0284-6012 3 Preface In March 2014, the then Minister for Integration Erik Ullenhag presented a White Paper entitled ‘The Dark Unknown History’. It describes an important part of Swedish history that had previously been little known. The White Paper has been very well received. Both Roma people and the majority population have shown great interest in it, as have public bodies, central government agencies and local authorities.
    [Show full text]
  • Introductory Guide for Authors This Guide Is for Early-Career Researchers Who Are Beginning to Write Papers for Publication
    Introductory guide for authors This guide is for early-career researchers who are beginning to write papers for publication. publishingsupport.iopscience.org publishingsupport.iopscience.org This guide is for early-career researchers who are beginning to write papers for publication. Academic publishing is rapidly changing, with new technologies and publication models giving authors much more choice over where and how to publish their work. Whether you are writing up the results of a PhD chapter or submitting your first paper, knowing how to prepare your work for publication is essential. This guide will provide an overview of academic publishing and advice on how to make the most of the process for sharing your research. For more information and to download a digital version of this guide go to publishingsupport.iopscience.org. c o n t e n t s Page Choosing where to submit your paper 4 Writing and formatting 6 Peer-review process 8 Revising and responding to referee reports 10 Acceptance and publication 12 Promoting your published work 13 Copyright and ethical integrity 14 Frequently asked questions 15 Publishing glossary 16 IOP publications 18 Introductory guide for authors 3 publishingsupport.iopscience.org Choosing where to submit your paper It can be tempting to begin writing a paper before giving much thought to where it might be published. However, choosing a journal to target before you begin to prepare your paper will enable you to tailor your writing to the journal’s audience and format your paper according to its specific guidelines, which you may find on the journal’s website.
    [Show full text]
  • Method of Tumor Treatment
    Europaisches Patentamt J European Patent Office 0 Publication number: 0 649 658 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION 0 Application number: 94202693.1 mt . ci .6 :A61K 31/53 0 Date of filing: 19.09.94 0 Priority: 22.09.93 US 125609 Palo Alto, CA 94304-1850 (US) 0 Date of publication of application: 0 Inventor: Brown, Martin J. 26.04.95 Bulletin 95/17 c/o Sterling Winthrop, Inc., 90 Park Avenue 0 Designated Contracting States: New York 10016 (US) AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE 0 Representative: Le Guen, Gerard 0 Applicant: THE BOARD OF TRUSTEES OF THE CABINET LAVOIX LELAND STANFORD JUNIOR UNIVERSITY 2, place d'Estienne d'Orves 900 Welch Road, Suite 350 F-75441 Paris Cedex 09 (FR) 0 Method of tumor treatment. 0 The present invention provides methods for increasing the cytotoxicity of a chemotherapy agent towards a solid tumor, such tumor susceptible to treatment with the chemotherapy agent, comprising administering to a mammal having such a tumor, from about one half hour to about twenty-four hours prior to administering the chemotherapy agent, or from about one hour to about two hours after administering the chemotherapy agent, a cytotoxicity-enhancing amount of a compound of Formula I. The invention also provides kits for treatment of such tumors which comprise a chemotherapy agent and a cytotoxicity-enhancing amount of a 1,2,4-ben- zotriazine oxide as defined in Formula I. The present invention also provides the use of a compound of Formula I capable of exerting a cytotoxic- enhancing effect on a cancer tumor for the manufacture of a medicament, for the therapeutic administration to a mammal having such a tumour from about one half hour to about twenty-four hours prior to treatment of said tumor with a chemotherapy agent.
    [Show full text]
  • Citation Overview of Mahidol University About Us Since 1874
    *data source: IOPscience dated 2020/9/15 Citation overview of Mahidol University Your top 5 popular journals of citations are: 3499 376 1. Astrophysical Journal Making an impact Your most cited paper 5 2. Nanotechnology Since the first paper, The spectrum of isotropic diffuse 3. Journal of Neural the research your gamma-ray emission between 100 Engineering institution has published MeV and 820 GeV has made a 4. Chinese Physics with IOP has collectively great impact with researchers in Letters achieved an impressive the field since it was published 5. Physics Education number of citations. in 2015. *data source: Scopus dated 2020/9/15 About us Since 1874, IOP Publishing has been delivering scientific publishing excellence through our strong portfolio of journals and ebooks, which includes some of the world’s leading specialist titles across the physics spectrum. Researchers and librarians are choosing IOP Publishing to secure first-rate research outcomes and support the success of their students. As the largest society physics publisher, we publish some of the world's leading specialist titles in fields across the physics spectrum; if your programme includes physics, materials science, astronomy and astrophysics, biosciences, nuclear or plasma science, then you can’t be without IOP content for the best research outcomes. Research impact • We publish 15% of the world’s very best physical sciences research; papers which receive 25 citations or more, and which represent the top 10% of published research. These are the papers being read, getting
    [Show full text]
  • Journal of Physics B Atomic, Molecular and Opt­Ical Physics
    iopscience.org journal of Physics B Atomic, Molecular and Opt ical Physics Highlight Papers 2009 Cover image: Time evolution of a probability distribution for a Gaussian mode profile J Larson J. Phys. B: At. Mol. Opt. Phys. 42 (2009) 044015. journal of Physics B: Atomic, Molecular and Optical Physics Journal of Physics B: Atomic, Molecular and Optical Physics highlights of 2009 offer you a representative cross section regarding breadth, quality and diversity of papers and fast track communications published last year in J. Phys. B. In our era of seemingly objective and quantitative indicators such as citations and downloads, this year we have simply asked our board members: what was your favorite J. Phys. B article in 2009 and why do you like it? Enjoy reading their IMPACT FACTOR highlights and find out if you agree with the selection - and 2.089* if not, there are many more excellent articles to be found in * As listed in ISI®’s 2008 Science J. Phys. B. Citation Index journal citation reports I thank all authors and referees who contribute to the journal Readership by regions in 2009 and support its vision: to be an intellectual market place ROW 11% North for exchanging interesting results and creative ideas. America 24% Asia 31% Europe 34% Editor-In-Chief Jan-Michael Rost Max-Planck-Institut für Physik komplexer Systeme, Dresden, Germany density profile plot of the stabilization of a rescattering electron intensity as a Tomographic imaging of the electron velocity short localized pulse due to the resonant function of rescattering time and the impact spectrum in elliptically polarized light, interaction with microwaves.
    [Show full text]
  • JULIA, ANNE, MARIE PONT Née Le 22 Avril 1975 À PARIS XVI
    ENVT ANNEE 2003 THESE : 2003- TOU 3 DES ANIMAUX, DES GUERRES ET DES HOMMES De l’utilisation des animaux dans les guerres de l’antiquité à nos jours THESE Pour obtenir le grade de DOCTEUR VETERINAIRE DIPLOME D’ETAT Présentée et soutenue publiquement en 2003 Devant l’Université Paul-Sabatier de Toulouse Par JULIA, ANNE, MARIE PONT Née le 22 avril 1975 à PARIS XVI Directeur de thèse : M. le Professeur Michel FRANC JURY Liste des professeurs 2 A Monsieur le Professeur …. 3 Professeur de la faculté de Médecine de Toulouse Qui nous a fait l’honneur d’accepter la présidence de notre jury de thèse A Monsieur le Professeur Michel Franc Professeur à l’Ecole Nationale Vétérinaire de Toulouse Qui a accepté de diriger cette thèse, pour la confiance et la patience qu’il a bien voulu m’accorder. Je vous témoigne toute ma gratitude et ma profonde reconnaissance. A Monsieur….. Professeur à l’Ecole Nationale vétérinaire de Toulouse Pour l’attention qu’il a bien voulu apporter à l’examen de ce travail 4 A mes parents, présents au jour le jour. Ce que je suis aujourd’hui je vous le dois. Vous m’avez épaulée dans chaque moment de ma vie, soutenue dans tous les tracas et les aléas de l’existence, poussée en avant pour tenter de donner le meilleur de moi-même. Si aujourd’hui je réalise mon rêve d’enfant, c’est en grande partie grâce à vous, à la ligne de conduite que vous m’avez montrée, autant dans ma vie personnelle que professionnelle.
    [Show full text]
  • Theranostics Self-Accelerating H2O2-Responsive Plasmonic
    Theranostics 2020, Vol. 10, Issue 19 8691 Ivyspring International Publisher Theranostics 2020; 10(19): 8691-8704. doi: 10.7150/thno.45392 Research Paper Self-accelerating H2O2-responsive Plasmonic Nanovesicles for Synergistic Chemo/starving therapy of Tumors Yao Tang1, Yuejia Ji1, Chenglin Yi2, Di Cheng1, Bin Wang1, Yun Fu1, Yufang Xu1, Xuhong Qian1, Yahya E. Choonara3, Viness Pillay3, Weiping Zhu1, Yunen Liu4 and Zhihong Nie2 1. State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China. 2. State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai 200438, China. 3. Department of Pharmacy and Pharmacology, University of the Witwatersrand, Parktown 2193 Johannesburg, South Africa. 4. Department of Emergency Medicine, the General Hospital of Northern Theater Command, Laboratory of Rescue Center of Severe Trauma PLA, Shenyang l10016, China. Corresponding author: E-mails: [email protected] (Z. Nie); [email protected] (Y. Liu); [email protected] (W. Zhu). © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.02.27; Accepted: 2020.06.17; Published: 2020.07.09 Abstract Rationale: Nanoscale vehicles responsive to abnormal variation in tumor environment are promising for use in targeted delivery of therapeutic drugs specifically to tumor sites. Herein, we report the design and fabrication of self-accelerating H2O2-responsive plasmonic gold nanovesicles (GVs) encapsulated with tirapazamine (TPZ) and glucose oxidase (GOx) for synergistic chemo/starving therapy of cancers.
    [Show full text]
  • Read & Publish Licence
    Read & Publish Licence THIS LICENCE IS AGREED BETWEEN IOP PUBLISHING LIMITED of Temple Circus, Temple Way, Bristol BS1 6HG England ("IOP") and KUNGLIGA BIBLIOTEKET (NATIONAL LIBRARY OF SWEDEN) ("Kungliga Biblioteket"), having its registered office at Box 5039, 102 41 Stockholm, Sweden (“the Consortium”) acting for and on behalf of its participating organisations (together the “Members”) whose institutional names, addresses and contact details are included in Schedule 3. References to the Consortium in these terms and conditions include members which are both commercial organisations and educational institutions, unless specified to the contrary. 1. IOP agrees that the Members may give Authorised Users (defined in standard condition 1) electronic access to the journals listed in Schedule 2 (the “Journals”), as part of IOPscience extra (the “Service”), subject to these terms and conditions. 2. The Members will access the Journals through the IP addresses set out in Schedule 3 or through IP addresses previously supplied to IOP (the “IP addresses”). The Members shall notify IOP in writing if the IP addresses previously supplied to IOP are now inaccurate or incomplete and shall also notify IOP in writing if, at any time during the term of this Licence, there are any changes to the IP addresses. 3. This Licence is subject to the IOP Standard Terms and Conditions which are set out in Schedule 1. 4. Any amendments to these terms and conditions must be in writing and signed by authorised signatories of both parties. 5. This Licence shall be for the initial term which is set out in Schedule 3. 6. Neither the Consortium nor any of the Members shall assign or transfer its right to access the Service to any other institution, organisation or person.
    [Show full text]
  • Iopscience Extra Content List
    IOPscience extra provides access to the full range of journal content listed below: Journal Title Online ISSN Website 2D Materials 2 2053-1583 iopscience.org/2dm 2014–2018 Advances in Natural Sciences: Nanoscience and Nanotechnology 1, 2 2043-6262 iopscience.org/ansn 2010–2018 Applied Physics Express 1882-0786 http://apex.jsap.jp 2008–2018 The Astronomical Journal 2 1538-3881 iopscience.org/aj 1998–2018 The Astrophysical Journal 2 1538-4357 iopscience.org/apj 1996–2018 The Astrophysical Journal Letters 2 2041-8213 iopscience.org/apjl 1995–2018 The Astrophysical Journal Supplement Series 2 1538-4365 iopscience.org/apjs 1996–2018 Biofabrication 2 1758-5090 iopscience.org/bf 2009–2018 Bioinspiration & Biomimetics 2 1748-3190 iopscience.org/bb 2006–2018 Biomedical Materials 2 1748-605X iopscience.org/bmm 2006–2018 Biomedical Physics & Engineering Express 2 2057-1976 iopscience.org/bpex 2015–2018 Chinese Physics B 2058-3834 iopscience.org/cpb 2008–2018 Formerly: Chinese Physics 2000–2007 Formerly: Acta Physica Sinica (Overseas edition) 1992–1999 Chinese Physics C 2058-6132 iopscience.org/cpc 2008–2018 Formerly: High Energy Physics and Nuclear Physics Chinese Physics Letters 1741-3540 iopscience.org/cpl 1984–2018 Classical and Quantum Gravity 1361-6382 iopscience.org/cqg 1984–2018 Communications in Theoretical Physics 1572-9494 iopscience.org/ctp 1982–2018 Computational Science and Discovery 2 1749-4699 iopscience.org/csd 2008–2015 Distributed Systems Engineering 1361-6390 1993–1999 Environmental Research Letters 1, 2 1748-9326 erl.iop.org &
    [Show full text]
  • BRAVE BIRDS By: PDSA - the UK’S Leading Veterinary Charity
    BRAVE BIRDS By: PDSA - the UK’s leading veterinary charity. Additional text and photos courtesy of Australian War Memorial and UK Flightglobal Archive. The most famous and the oldest of the charity’s awards is the PDSA Dickin Medal. It acknowledges outstanding acts of bravery displayed by animals serving with the Armed Forces or Civil Defence units in any theatre of war, worldwide. The Medal is recognised as the animals’ Victoria Cross and is the highest British honour for animal bravery in military conflicts. The medal was instituted in 1943 Maria Dickin. Maria Dickin CBE PDSA owes its foundation to the vision of one woman - Maria Elisabeth Dickin - and her determination to raise the status of animals, and the standard of their care, in society. During the First World War, Maria Dickin CBE worked to improve the dreadful state of animal health in the Whitechapel area of London. She wanted to open a clinic where East Enders living in poverty could receive free treatment for their sick and injured animals. Left: Despite the scepticism of the Establishment, Maria Dickin opened her free 'dispensary' in a Whitechapel basement on Saturday 17th November 1917. It was an immediate success and she was soon forced to find larger premises. Photo PDSA. Within six years this extraordinary woman had designed and equipped her first horse-drawn clinic and soon a fleet of mobile dispensaries was established. PDSA vehicles soon became a comforting and familiar sight throughout the country. With success came increased attention from her critics at the Royal College of Veterinary Surgeons and the Ministry of Agrigulture.
    [Show full text]